Answers are grounded in this paper and cite their sources.
Case report reveals progressive eczematous dermatitis in a patient with hidradenitis suppurativa, suggesting management insights for similar cases.
A patient with hidradenitis suppurativa developed a progressive eczematous drug reaction to bimekizumab. The eczematous dermatitis presented in a unique distribution primarily in areas of prior hidradenitis suppurativa. We discuss our management approach, which could help clinicians who are treating similar patients.
No takes yet. Share an insight, caveat, or question.
Houff et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: